Trials / Recruiting

RecruitingNCT05418218

International Headache Registry Study

International Headache and Vertigo Registration Study

Status: Recruiting
Phase: —
Study type: Observational
Enrollment: 200,000 (estimated)

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex: All
Age: 4 Years – 99 Years
Healthy volunteers: Accepted

Summary

In the International Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned.

Detailed description

1. Research contents: In the International Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned. 2. Research target: We study biomarkers, imaging features, right-to-left shunt of heart (lung), genetic features, real-world treatment studies, and outcomes (in relation to other diseases) for headache and vertigo related diseases.

Conditions

Timeline

Start date: 2021-07-12
Primary completion: 2082-12-31
Completion: 2082-12-31
First posted: 2022-06-14
Last updated: 2025-05-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05418218. Inclusion in this directory is not an endorsement.